Pilot Randomized Controlled Trial of Telemedicine for Individuals With Parkinson Disease in a Rural Population
NCT ID: NCT00668551
Last Updated: 2009-04-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
14 participants
OBSERVATIONAL
2008-04-30
2008-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We hypothesize that this telemedicine model will in time improve access to care and hence the quality of life and quality of care of individuals with PD.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Remote Access to Care, Everywhere, for Parkinson Disease
NCT02144220
Connect.Parkinson: Connecting Individuals With Parkinson Disease to Specialists in Their Homes
NCT02038959
Providing Specialty Care to Individuals With Parkinsonism Directly in Their Homes Via Web-based Video Conferencing- A Comparative Effectiveness Study
NCT01476306
Comparison of Health Care Delivery Methods in Parkinson's Disease
NCT05725772
Automated Telehealth Diagnostics for Remote Parkinson Monitoring
NCT02152319
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Each telemedicine visit (Month 1, Month 3, Month 6) will take place in a 1:1 fashion between the study participant and the physician investigator - one of two movement disorder specialists from the University of Rochester - via televideo linkage, and will last approximately 30-60 minutes. The study participant will be observed by the physician investigator and she/he will be accompanied by a Presbyterian Home staff member to ensure safety throughout the telemedicine visit. The visit will be structured much the same as a standard clinical visit and will include:
* Study participant's update on his or her clinical condition
* Review of current medications, which will be provided in advance of the visit
* Review and update of medical and social histories
* Vital signs, including weight (provided by the Presbyterian Home staff)
* Pertinent neurological exam, including a modified motor examination led by physician investigator
* Assessment of current clinical state
* Dictated recommendations including a letter to the attending physician for ongoing clinical care, including changes to the PD medications
Participants assigned to the control group will receive their care as routinely scheduled with their own primary care physician and/or neurologist.
Staff members from the University of Rochester will return to the Presbyterian Home within one month of the six month study to complete final assessments with all study participants. These will include:
* Reportable events form
* Health care events form
* Quality of life and healthcare evaluation surveys
* Continuation of care survey
* 1:1 interviews
* Telemedicine focus groups
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Telemedicine care
No interventions assigned to this group
2
Standard of care
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 30 years old or older
* Clinical diagnosis of idiopathic Parkinson's disease as determined by having two of the four cardinal features of PD (rest tremor, bradykinesia, cogwheel rigidity, and gait instability) and no better alternative explanation for the etiology of the symptoms
* Able to converse in English
* Willing and able to complete study requirements
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Presbyterian Homes & Services
OTHER
University of Rochester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Rochester
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
E. Ray Dorsey, MD, MBA
Role: PRINCIPAL_INVESTIGATOR
University of Rochester
Kevin Biglan, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Rochester
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Presbyterian Home for Central New York, Inc.
New Hartford, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hubble JP, Pahwa R, Michalek DK, Thomas C, Koller WC. Interactive video conferencing: a means of providing interim care to Parkinson's disease patients. Mov Disord. 1993 Jul;8(3):380-2. doi: 10.1002/mds.870080326.
Cheng EM, Swarztrauber K, Siderowf AD, Eisa MS, Lee M, Vassar S, Jacob E, Vickrey BG. Association of specialist involvement and quality of care for Parkinson's disease. Mov Disord. 2007 Mar 15;22(4):515-22. doi: 10.1002/mds.21311.
McConnochie KM, Wood NE, Kitzman HJ, Herendeen NE, Roy J, Roghmann KJ. Telemedicine reduces absence resulting from illness in urban child care: evaluation of an innovation. Pediatrics. 2005 May;115(5):1273-82. doi: 10.1542/peds.2004-0335.
Samii A, Ryan-Dykes P, Tsukuda RA, Zink C, Franks R, Nichol WP. Telemedicine for delivery of health care in Parkinson's disease. J Telemed Telecare. 2006;12(1):16-8. doi: 10.1258/135763306775321371.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RSRB00022923
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.